Exploring the potential of the vitamin B12 derivative azidocobalamin to undergo Huisgen 1,3-dipolar azide-alkyne cycloaddition reactions

Ben J Stackpole,Jessica M Fredericksen,Nicola E Brasch,Ben J. Stackpole,Jessica M. Fredericksen,Nicola E. Brasch
DOI: https://doi.org/10.1016/j.jinorgbio.2024.112504
IF: 4.336
2024-05-01
Journal of Inorganic Biochemistry
Abstract:There is considerable interest in using the metalloprotein cofactor vitamin B<sub>12</sub> as a vehicle to deliver drugs and diagnostic agents into mammalian or bacterial cells by exploiting the B<sub>12</sub>-specific active uptake pathways. Conjugation of the cargo via the β-axial site or the 5'-OH of the ribose of the nucleotide are the most desirable sites, to maximise intracellular uptake. Herein we show the potential of conjugation at the beta-azido ligand of the vitamin B<sub>12</sub> derivative azidocobalamin via a click-type azide-alkyne 1,3-dipolar cycloaddition (Huisgen cycloaddition) reaction. Reacting azidocobalamin with dimethyl acetylenedicarboxylate at 40 °C results in essentially stoichiometric conversion of azidocobalamin to the corresponding triazolato complex. The stability of the complex as a function of pH and in the presence of cyanide were investigated. The complex is stable in pD 7.0 phosphate buffer for 24 h. The rate of beta-axial ligand substitution was found to be one order of magnitude slower for the triazolatocobalamin complex compared with azidocobalamin.
biochemistry & molecular biology,chemistry, inorganic & nuclear
What problem does this paper attempt to address?